Equity Profile
Post-Earnings Recap
CRISPR Therapeutics AG
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.39 | $0.34 | +11.43% |
| Revenue | — | $553M | — |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Concentra Group Holdings Parent, Inc. operates in the health care sector, focusing on health care facilities....
EPS
Earnings per share is a key indicator of profitability and helps gauge the company's financial health.
Revenue
Total revenue reflects the company's ability to generate sales and is crucial for assessing growth.
Wall Street expectations, options signals, track record, and call prep available with Pro.